Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Quintiliani

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Current Opinion in Pulmonary Medicine|April 12, 2003
Inhalational anthrax and bioterrorismRichard Quintiliani, Richard Quintiliani
Connecticut Medicine|June 20, 2002
Fatal case of inhalational anthrax mimicking intra-abdominal sepsisRichard Quintiliani, Richard Quintiliani
Critical Care Clinics|March 26, 2008
Pharmacokinetics/Pharmacodynamics for critical care cliniciansRichard Quintiliani, Richard Quintiliani
Connecticut Medicine|June 1, 1978
"Should she or shouldn't she" receive the rubella immunization before age 12Martha L Lepow, Richard Quintiliani
The Journal of Antimicrobial Chemotherapy|November 14, 2022
Relative bioavailability of crushed tebipenem administered through a nasogastric tube with and without enteral feedingAliaa Fouad, Richard Quintiliani, David P Nicolau, et al.
Journal of Clinical Pharmacology|August 7, 2002
Minimal interaction between gatifloxacin and oxycodoneEdward M Grant, David R Nicolau, Charles Nightingale, et al.
Chest|May 5, 2011
Pneumonia due to Pseudomonas aeruginosa: part II: antimicrobial resistance, pharmacodynamic concepts, and antibiotic therapyHsin-Yun Sun, Shigeki Fujitani, Richard Quintiliani, et al.
Connecticut Medicine|February 21, 2002
Extended-spectrum beta-lactamases (ESBL)Prachi K Dandekar, Richard Quintiliani, Charles H Nightingale, et al.
Diagnostic Microbiology and Infectious Disease|October 12, 2002
Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysisJoseph L Kuti, Charles H Nightingale, Richard Quintiliani, et al.
The Journal of Antimicrobial Chemotherapy|January 20, 2004
Pharmacodynamic study of beta-lactams alone and in combination with beta-lactamase inhibitors against Pseudomonas aeruginosa possessing an inducible beta-lactamaseChonghua Li, David P Nicolau, Philip D Lister, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Opinion in Pulmonary Medicine|April 12, 2003
Inhalational anthrax and bioterrorismRichard Quintiliani, Richard Quintiliani
Connecticut Medicine|June 20, 2002
Fatal case of inhalational anthrax mimicking intra-abdominal sepsisRichard Quintiliani, Richard Quintiliani
Critical Care Clinics|March 26, 2008
Pharmacokinetics/Pharmacodynamics for critical care cliniciansRichard Quintiliani, Richard Quintiliani
Connecticut Medicine|June 1, 1978
"Should she or shouldn't she" receive the rubella immunization before age 12Martha L Lepow, Richard Quintiliani
The Journal of Antimicrobial Chemotherapy|November 14, 2022
Relative bioavailability of crushed tebipenem administered through a nasogastric tube with and without enteral feedingAliaa Fouad, Richard Quintiliani, David P Nicolau, et al.
Journal of Clinical Pharmacology|August 7, 2002
Minimal interaction between gatifloxacin and oxycodoneEdward M Grant, David R Nicolau, Charles Nightingale, et al.
Chest|May 5, 2011
Pneumonia due to Pseudomonas aeruginosa: part II: antimicrobial resistance, pharmacodynamic concepts, and antibiotic therapyHsin-Yun Sun, Shigeki Fujitani, Richard Quintiliani, et al.
Connecticut Medicine|February 21, 2002
Extended-spectrum beta-lactamases (ESBL)Prachi K Dandekar, Richard Quintiliani, Charles H Nightingale, et al.
Diagnostic Microbiology and Infectious Disease|October 12, 2002
Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysisJoseph L Kuti, Charles H Nightingale, Richard Quintiliani, et al.
The Journal of Antimicrobial Chemotherapy|January 20, 2004
Pharmacodynamic study of beta-lactams alone and in combination with beta-lactamase inhibitors against Pseudomonas aeruginosa possessing an inducible beta-lactamaseChonghua Li, David P Nicolau, Philip D Lister, et al.
Pageof 3